Report Detail

TABLE OF CONTENTS

    1. Introduction

    • 1.1 Scope of the Study
    • 1.2 The Insight Partners Research Report Guidance
    • 1.3 Market Segmentation
      • 1.3.1 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Software Type
      • 1.3.2 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Delivery Mode
      • 1.3.3 Global Pharmacovigilance (PV) and Drug Safety Software Market – By End User
      • 1.3.4 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Geography

    2. Global Pharmacovigilance (PV) and Drug Safety Software Market – Key Takeaways

      3. Research Methodology

      • 3.1 Coverage
      • 3.2 Secondary Research
      • 3.3 Primary Research

      4. Global Pharmacovigilance (PV) and Drug Safety Software Market – Market Landscape

      • 4.1 Overview
      • 4.2 PEST Analysis
        • 4.2.1 North America PEST Analysis
        • 4.2.2 Europe PEST Analysis
        • 4.2.3 Asia Pacific PEST Analysis
        • 4.2.4 Middle East & Africa PEST Analysis
        • 4.2.5 South & Central America PEST Analysis
      • 4.3 Expert Opinions

      5. Global Pharmacovigilance (PV) and Drug Safety Software Market – Key Industry Dynamics

      • 5.1 Key Market Drivers
        • 5.1.1 Rising Incidences Of Adverse Drug Reactions (ADRs
        • 5.1.2 Globalization Of Pharmacovigilance
      • 5.2 Key Market Restraints
        • 5.2.1 Expensive Technology
      • 5.3 Key Market Opportunities
        • 5.3.1 Growth Opportunities in Developing Countries
      • 5.4 Future Trends
        • 5.4.1 Artificial Intelligence In Pharmacovigilance
      • 5.5 Impact Analysis

      6. Pharmacovigilance (PV) and Drug Safety Software Market – Global Analysis

      • 6.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Revenue Forecasts And Analysis
      • 6.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography - Forecasts And Analysis
      • 6.3 Performance of Key Players

      7. Global Pharmacovigilance (PV) And Drug Safety Software Analysis– by Software Type

      • 7.1 Overview
      • 7.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Product & Services 2018 & 2027 (%)
      • 7.3 Adverse Event Reporting Software Market
        • 7.3.1 Overview
        • 7.3.2 Global Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)
      • 7.4 Drug Safety Audits Software
        • 7.4.1 Overview
        • 7.4.2 Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)
      • 7.5 Issue Tracking Software
        • 7.5.1 Overview
        • 7.5.2 Global Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)
      • 7.6 Fully Integrated Software
        • 7.6.1 Overview
        • 7.6.2 Global Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

      8. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis– by Delivery Mode

      • 8.1 Overview
      • 8.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2018 & 2027 (%)
      • 8.3 On-premise Market
        • 8.3.1 Overview
        • 8.3.2 Global On-premise Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.4 Cloud- Based Market
        • 8.4.1 Overview
        • 8.4.2 Global Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

      9. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis– by End User

      • 9.1 Overview
      • 9.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By End User

      2018 & 2027 (%)

      • 9.3 Pharmaceutical and Biotech Companies Market
        • 9.3.1 Overview
        • 9.3.2 Global Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4 Contract Research Organizations (CROs) Market
      • 9.4.1.1 Overview
      • 9.4.1.2 Global Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.5 Business Process Outsourcing (BPO) Firms Market
      • 9.5.1 Overview
      • 9.5.2 Global Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)
    • 10. Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 – Geographical Analysis

      • 10.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
        • 10.1.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.1.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.1.2.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.1.2.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.1.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
        • 10.1.4 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.1.5 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.1.6 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.1.6.1 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.1.6.2 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.1.7 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.1.7.1 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.1.8 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.1.8.1 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.1.8.2 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.1.9 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.1.9.1 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.1.10 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.1.10.1 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.1.10.2 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      • 10.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
        • 10.2.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.2.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
        • 10.2.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.2.3.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.2.3.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.2.4 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
        • 10.2.5 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.2.6 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.2.7 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.2.7.1 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.2.7.2 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.2.8 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.2.8.1 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.2.9 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.2.9.1 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.2.9.2 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
          • 10.2.9.3 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.2.10 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.2.11 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.2.11.1 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.2.11.2 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.2.12 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.2.12.1 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.2.13 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.2.13.1 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.2.13.2 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.2.14 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.2.15 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.2.16 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.2.16.1 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.2.16.2 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      • 10.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
        • 10.3.1 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.2 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.3.2.1 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.3.2.2 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.3.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
        • 10.3.4 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.5 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.6 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.3.6.1 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.3.6.2 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
          • 10.3.6.3 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.7 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.8 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.3.8.1 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.3.8.2 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.3.9 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.10 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.11 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.3.11.1 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.3.11.2 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.3.12 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.13 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.14 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.3.14.1 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.3.14.2 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.3.15 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.16 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.3.17 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.3.17.1 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.3.17.2 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      • 10.4 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
        • 10.4.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.4.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.4.2.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.4.2.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.4.3 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
        • 10.4.4 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.4.5 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.4.6 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.4.6.1 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.4.6.2 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.4.7 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
          • 10.4.7.1 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.4.8 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.4.8.1 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.4.8.2 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.4.9 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.4.10 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.4.11 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.4.11.1 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.4.11.2 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      • 10.5 South And Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
        • 10.5.1 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.5.2 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
        • 10.5.3 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.5.3.1 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.5.3.2 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.5.4 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
        • 10.5.5 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.5.6 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.5.7 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.5.7.1 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.5.7.2 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 10.5.8 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.5.9 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
        • 10.5.10 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
          • 10.5.10.1 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
          • 10.5.10.2 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

        11. Pharmacovigilance (PV) and Drug Safety Software Market –Industry Landscape

        • 11.1 Overview
        • 11.2 Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019
        • 11.3 Organic Developments
          • 11.3.1 Overview
          • 11.3.2 Organic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019
        • 11.4 Inorganic Developments
          • 11.4.1 Overview
          • 11.4.2 Inorganic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019

        12. Pharmacovigilance (PV) and Drug Safety Software Market–Key Company Profiles

        • 12.1 AB Cube
          • 12.1.1 Key Facts
          • 12.1.2 Business Description
          • 12.1.3 Financial Overview
          • 12.1.4 Product Portfolio
          • 12.1.5 SWOT Analysis
          • 12.1.6 Key Developments
        • 12.2 UNITED BIOSOURCE LLC
          • 12.2.1 Key Facts
          • 12.2.2 Business Description
          • 12.2.3 Financial Overview
          • 12.2.4 Product Portfolio
          • 12.2.5 SWOT Analysis
          • 12.2.6 Key Developments
        • 12.3 ArisGlobal LLC
          • 12.3.1 Key Facts
          • 12.3.2 Business Description
          • 12.3.3 Financial Overview
          • 12.3.4 Product Portfolio
          • 12.3.5 SWOT Analysis
          • 12.3.6 Key Developments
        • 12.4 Sparta Systems
          • 12.4.1 Key Facts
          • 12.4.2 Business Description
          • 12.4.3 Financial Overview
          • 12.4.4 Product Portfolio
          • 12.4.5 SWOT Analysis
          • 12.4.6 Key Developments
        • 12.5 Oracle
          • 12.5.1 Key Facts
          • 12.5.2 Business Description
          • 12.5.3 Financial Overview
          • 12.5.4 Product Portfolio
          • 12.5.5 SWOT Analysis
          • 12.5.6 Key Developments
        • 12.6 Sarjen Systems Pvt. Ltd
          • 12.6.1 Key Facts
          • 12.6.2 Business Description
          • 12.6.3 Financial Overview
          • 12.6.4 Product Portfolio
          • 12.6.5 SWOT Analysis
          • 12.6.6 Key Developments
        • 12.7 EXTEDO
          • 12.7.1 Key Facts
          • 12.7.2 Business Description
          • 12.7.3 Financial Overview
          • 12.7.4 Product Portfolio
          • 12.7.5 SWOT Analysis
          • 12.7.6 Key Developments
        • 12.8 ENNOV
          • 12.8.1 Key Facts
          • 12.8.2 Business Description
          • 12.8.3 Financial Overview
          • 12.8.4 Product Portfolio
          • 12.8.5 SWOT Analysis
          • 12.8.6 Key Developments
        • 12.9 Maxapplication
          • 12.9.1 Key Facts
          • 12.9.2 Business Description
          • 12.9.3 Financial Overview
          • 12.9.4 Product Portfolio
          • 12.9.5 SWOT Analysis
          • 12.9.6 Key Developments
        • 12.10 Online Business Applications, Inc.
          • 12.10.1 Key Facts
          • 12.10.2 Business Description
          • 12.10.3 Financial Overview
          • 12.10.4 Product Portfolio
          • 12.10.5 SWOT Analysis
          • 12.10.6 Key Developments

        13. Appendix

        • 13.1 About The Insight Partners
        • 13.2 Glossary Of Terms

      Pharmacovigilance (PV) And Drug Safety Software Market to 2027 – Global Analysis and Forecasts by Software Type, Delivery Mode, End User, and Geography
      The global pharmacovigilance (PV) and drug safety software market is expected to reach US$ 262.02 Mn in 2027 from US$ 151.07 Mn in 2018. The pharmacovigilance (PV) and drug safety software market is estimated to grow with a CAGR of 6.4% from 2019-2027.
      The market is driven by factors such as, rising incidences of adverse drug reactions (ADRs) and globalization of pharmacovigilance. However, expensive technology may limit the growth of the market to a certain extent.
      The pharmacovigilance (PV) and drug safety software are used to recognize the cause of drug withdrawal and helps to inhibit unnecessary future events. These software are beneficial to those involved in drug making process like clinical research organization and pharmaceutical companies. These software help companies to manage huge data generated due to adverse drug reaction events. Help to maintain data for regulatory inspection and approval. These software lets global information to be shared rapidly and economically.
      Though there are many advantages of pharmacovigilance (PV) and drug safety software the software deployment cost is expensive. Large pharma companies having good infrastructure for pharmacovigilance process in house prefer for on-premise. These require huge capital upfront. Hence, high price for installation of pharmacovigilance (PV) and drug safety software is anticipated to hinder the growth of market.
      Global pharmacovigilance (PV) and drug safety software market was segmented by software type, delivery mode and end user. The software type was segmented as fully integrated software, adverse event reporting software, drug safety audits software, and issue tracking software. By delivery mode it is categorized in on-premise and cloud based. By end user contract research organizations (CRO’s), pharmaceutical and biotech companies, business process outsourcing.
      Some of the major primary and secondary sources included in the report are, Drug Safety and Effectiveness Network, European Medicines Agency, Food and Drug Administration, National Adverse Drug Event Monitoring Centre, National Center for Biotechnology Information, Pharmacovigilance Program of India, World Health Organization, Canadian Institutes of Health Research, Indian Council of Medical Research, Federation of Pharmaceutical Industries and Associations among others.


      Summary:
      Get latest Market Research Reports on Pharmacovigilance (PV) and Drug Safety Software . Industry analysis & Market Report on Pharmacovigilance (PV) and Drug Safety Software is a syndicated market report, published as Pharmacovigilance (PV) and Drug Safety Software Market to 2027 - Global Analysis and Forecasts By Software Type ( Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software ); Delivery Mode ( On-premise, Cloud-based ); End User ( Pharmaceutical and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Pharmacovigilance Service Providers ),and Geography. It is complete Research Study and Industry Analysis of Pharmacovigilance (PV) and Drug Safety Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,550.00
      $6,550.00
      $8,550.00
      3,594.40
      5,174.35
      6,754.30
      4,019.54
      5,786.37
      7,553.21
      497,547.05
      716,249.05
      934,951.05
      343,934.05
      495,113.85
      646,293.65
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report